News
Patients with psoriasis have significantly more difficulty sleeping, particularly in new environments, than matched ...
Moving on, Regeneron’s second-quarter report was largely positive. Total revenues of $3.68 billion (up 4% YoY) beat analyst ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) awarded the 13th annual Regeneron Prize for ...
Shares of Regeneron Pharmaceuticals Inc. slipped 3.03% to $545.94 Monday, on what proved to be an all-around poor trading ...
Regeneron Court Permits Government to Pursue False Certification Theory - On August 4, the district court in the closely ...
Plus more pharma news from the Pharmalittle newsletter.
Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on ...
JPMorgan (NYSE: JPM) told investors in a note Monday that Eli Lilly & Co. (NYSE: LLY) shares are its “top pick” among U.S.
Dr. Reid brings 30 years of experience in building biotech companies based on innovative scientific platforms and shaping ...
6h
Stocktwits on MSNThis Stock Has Tumbled 50% In One Year, Gets A Price Target Cut Today – But Retail Believes $400-450 Is A Good Entry PointTruist on Monday lowered its price target on Regeneron (REGN) to $812 from $940, citing concerns with the company’s Eylea ...
Adam Kovalčík, a 19-year-old from Slovakia, secured a top prize at an international science competition. He developed a ...
In August 2025, Bayer announced a study of researchers will check the medical history and current medications of the participants. They will also perform a complete health check-up of all the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results